Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103232467B reveals novel Sinomenine modifications offering superior anti-inflammatory activity and scalable synthesis for global pharmaceutical supply chains.
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.
Patent CN117105967A reveals gold-catalyzed synthesis for high-purity organosilanes. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN1144781C details a novel hydrocyanation method for C5 mononitriles using selective hydrogenation, offering significant cost reduction and improved catalyst recovery for industrial scale-up.
Patent CN113979937A reveals a novel photocatalytic route for quinoline derivatives, eliminating strong oxidants to reduce equipment corrosion and lower manufacturing costs.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Patent CN114751849A reveals a novel asymmetric Baeyer-Villiger oxidation route for brivaracetam intermediates, offering superior chiral purity and significant cost reduction in API manufacturing.
Patent CN101717320B details a green, one-pot Mannich base synthesis using water and liquid superacids. Discover cost-effective manufacturing and high-purity intermediates.
Novel microwave-assisted route eliminates chromatography, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN104725174B reveals metal-free biaryl synthesis. Reduces metal waste and simplifies purification for pharmaceutical intermediates supply chain.
Patent CN102603570A reveals a novel one-step ionic liquid cyanation method. Achieve significant cost reduction in pharma intermediates manufacturing with high purity.
Advanced microwave-assisted solid-phase synthesis for Leuprorelin. High purity, simplified process, cost-effective manufacturing for pharmaceutical supply chains.
Patent CN100432060C details advanced synthesis of levofloxacin intermediates. Enhance supply chain reliability and reduce manufacturing costs with optimized chiral resolution.
Patent CN112939798A reveals a green amidation route for amantadine using PIL-1, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Novel 4-step synthesis for liquid crystal intermediates. High yield, green oxidation, cost-effective manufacturing for reliable supply chain partners.
Discover the novel photocatalytic route for 1,2,4-triazole compounds in patent CN111518042A. Achieve high purity and safety without explosive azides for scalable manufacturing.
Novel CSA-catalyzed route offers high yield and room temperature operation for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN101314581B details a gold-catalyzed synthesis of N-sulfonyl ketimines offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN115739184B reveals a novel Rhodium catalyst for diisobutylene hydroformylation, offering high selectivity and supply chain stability for plasticizer intermediates.